Janus Henderson Group PLC Ptc Therapeutics, Inc. Call Options Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PTCT
# of Institutions
229Shares Held
79.1MCall Options Held
164KPut Options Held
220K-
Vanguard Group Inc Valley Forge, PA9.13MShares$402 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.21MShares$361 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$342 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$326 Million3.78% of portfolio
-
Armistice Capital, LLC New York, NY6.96MShares$307 Million2.77% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.15B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...